Delivery Order SPE2DB24D2109-SPE2DB25FHWRN
Award Date
4/2/25
Potential Completion Date
4/23/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,654.33, is for the delivery of PROQUAD VIALS, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 16, 2025. The contract was awarded on March 26, 2025, and has no set-aside designation, indicating open...
This federal contract award, valued at $3,203.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a medical product, with a completion date of February 6, 2024. This award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,871.34 firm fixed-price delivery order contract is for the supply of PROQUAD VIALS, a medical product, with a completion date of January 21, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,645.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a medical product, and has an ultimate completion date of January 3, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical....
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,067.98, is a delivery order for the supply of PROQUAD VIALS, a medical product. The contract is not designated as a set-aside and is a firm fixed-price agreement. It has an ultimate completion date of May 14, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,874.80, is a delivery order for PROQUAD VIALS. It has a firm fixed price and an ultimate completion date of March 3, 2025. This contract is not designated as a set-aside. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,221.47, is for the delivery of PROQUAD VIALS, a medical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 28, 2025. The contract was awarded on April 7, 2025 and does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $10,745.76, is for the delivery of PROQUAD VIALS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 23, 2025. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,247.58 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a medical product. The contract has a completion date of December 26, 2024 and was awarded on December 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $16,543.30 delivery order contract is for the supply of PROQUAD VIALS, a medical product. The contract is a Firm Fixed Price, Delivery Order type with a period of performance through March 11, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...